IFNG and colitis: Lgr5, a marker of intestinal stem cells, was significantly (p < 0.05 and p < 0.01, respectively) increased in the mice treated with both IFN-γ-primed and naïve cAMSCs compared to in the DSS-induced colitis mice (Figure 5).